EXACT SCIENCES CORP 4

James Edward Doyle tendered and cashed out a total of 52,564 shares of Exact Sciences Corporation common stock at $105.00 per share in the Abbott merger, leaving him with no remaining shares.

On March 23, 2026, reporting person James Edward Doyle disposed of all his Exact Sciences Corporation common shares in connection with the closing of the cash merger with Abbott Laboratories. Each of his 52,564 previously held common shares, including 5,398 shares subject to vesting or other restrictions that were accelerated and cancelled at the effective time, was converted into the right to receive $105.00 in cash per share under the merger agreement. Following these transactions, Doyle no longer holds any Exact Sciences common stock, as the issuer became a wholly owned subsidiary of Abbott and all equity was cashed out at the merger consideration price.

Filing Facts

CIK

1124140

Ticker

EXAS

Form

4

Source Type

sec

Accession

0001193125-26-118744

Alert Tier

7